Effectiveness and tolerability of treatment intensification to basal–bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study

BACKGROUND: Due to the progressive nature of type 2 diabetes mellitus (T2DM), antidiabetic treatment needs to be continuously intensified to avoid long-term complications. In T2DM patients on either basal insulin-supported oral therapy (BOT) or supplementary insulin therapy (SIT) presenting with HbA...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Vasc Health Risk Manag
Main Authors: Pfohl, Martin, Siegmund, Thorsten, Pscherer, Stefan, Pegelow, Katrin, Seufert, Jochen
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2015
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642811/
https://ncbi.nlm.nih.gov/pubmed/26604774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S82720
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים